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A recent commentary reignited 
discussion within this journal about 
the access by clinicians to the up-
dated Australian National Guidelines on 
Attention Deficit Hyperactivity Disorder 
(ADHD) (The Royal Australian Col-
lege of Physicians, 2009). We seek to 
extend this debate by noting that the 
new Diagnostic and Statistical Manual 
of Mental Disorders (DSM-5) included 
a number of changes to the defini-
tion of ADHD. Given the reliance of 
these draft national guidelines on the 
DSM-IV, it can be expected that the 
DSM-5 changes will also have signif-
icant impact on the future form of 
guidelines, research and clinical prac-
tice (Al-Yagon et al., 2013). Further, 
the high prevalence of ADHD makes 
it important for clinicians to under-
stand these recent changes and their 
implications for diagnosis and treat-
ment (Bell, 2011). 
There are five major changes in the 
new DSM-5. First, a number of exam-
ples have been included to elaborate 
the types of behavior that people with 
ADHD may exhibit across the lifespan. 
Second, the age before which symp-
toms must be manifested has been in-
creased from 7 to 12 years. Third, the 
number of symptoms required for 
those over 17 years has been reduced 
from six to five. Fourth, the previous 
exclusion criterion for ADHD and au-
tism has been removed. Finally, greater 
emphasis has been placed on the iden-
tification of symptoms across several 
settings. While the purpose of these 
changes is to more accurately incor-
porate the experience of adults af-
fected by ADHD, possible knock-on 
effects to pediatrics have been sug-
gested (Sibley et al., 2013). 
Estimated prevalence of ADHD in 
Australia is between 5 and 10% (The 
Royal Australian College of Physi-
cians, 2009). Historically, changes to 
the DSM criteria have resulted in in-
creases in ADHD diagnosis, at times 
as much as 15% (Bastra and Fran-
ces, 2012). The DSM-5 changes have 
the potential for similar increases in 
ADHD prevalence and concomitant 
psychostimulant treatment (Coghill 
and Seth, 2011; Sibley et al., 2013). 
However, it is pertinent to exam-
ine evidence-based critiques of the 
DSM-5 changes and their implications 
for clinical practice. 
The main critique of the above 
changes is that they have not been 
fully clinically tested (Coghill and Seth, 
2011; Hebebrand and Buitelaar, 2011; 
Sibley et al., 2013). Questions have 
also been raised about the blurring of 
subtypes and the potential for confu-
sion with comorbid conditions (Bastra 
and Frances, 2012). For some, this is 
a positive move that enables diagnos-
tic practices to cater for individual di-
versity (Bell, 2011), while for others, it 
leaves the potential for greater misdi-
agnosis (Bastra and Frances, 2012). 
The increase of age onset from 7 
to 12 years has also been subject to 
critique. Although it is acknowledged 
that there is no empirical evidence to 
support either age (Coghill and Seth, 
2011), the lower age has been pre-
ferred in the past because it removes 
puberty and transition into second-
ary schooling as confounding variables 
that may influence behavior (Bastra 
and Frances, 2012). The shift to the 
older age is intended to allow more 
accurate diagnosis of adolescents and 
adults (Bell, 2011). However, lifting the 
age of onset, combined with the re-
quirement to show only symptoms 
in the past (rather than impairment), 
may increase levels of diagnosis (Sibley 
et al., 2013). 
A less controversial change is the 
greater emphasis on identifying dif-
ficulties across multiple settings and 
the need to rely on reports from 
third parties in each of these con-
texts. Those familiar with the DSM-
IV might observe that this is little 
change from the previous require-
ments. And while Coghill and Seth 
(2011) argue that assessing across 
settings is commonplace in the UK, 
Epstein and colleagues (2009) have 
found that in North America less 
than 50% of diagnosticians go beyond 
parental reports of a child’s behavior. 
There is a lack of empirical evidence 
on this trend in Australia. 
What the above changes have 
in common is the likelihood of in-
creased diagnosis and psychostimulant 
treatment (Hebebrand and Buitelaar, 
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2011). This would result in a grow-
ing demand on clinical services, which 
would result in increased health costs 
through the MBS and PBS, and possi-
bly in private costs for families. In the 
context of existing medical workforce 
shortages, already tight time demands 
and limited GP training on ADHD, 
two outcomes are possible: (i) less 
rigorously examined assessments by 
GPs, and/or (ii) increased referrals to 
psychiatric specialists. 
In Australia, only authorized medi-
cal practitioners can diagnose ADHD 
and prescribe psychostimulants. Best 
practice guidelines recommend that 
GPs refer to psychiatrists and pedia-
tricians for diagnosis and prescription 
(The Royal Australian College of Phy-
sicians, 2009). In some states and ter-
ritories, high levels of demand have 
resulted in GPs and psychologists be-
ing authorized as delegates to initiate 
or continue treatment. In others, the 
concentration of ADHD diagnosis in 
the hands of a few specialists has also 
been noted (Paterson, 2013). Both sit-
uations can contribute even further to 
a significant difference in prescribing 
practices between medical practitio-
ners (Mitchell et al., 2012). 
Within the USA, uniformity in di-
agnostic and prescription practices is 
supported by the American Academy 
of Child and Adolescent Psychiatry. 
In Australia, the Royal Australian and 
New Zealand College of Psychiatrists 
has produced routine prescribing cri-
teria for ADHD, which some states 
(e.g. NSW) use to allow members to 
prescribe without seeking individual 
approval for each child. However, such 
arrangements are not widespread and 
the number of child and adolescent 
psychiatrists in Australia is in the low 
hundreds. This means that many chil-
dren are treated by private pediatri-
cians, which provides the potential for 
idiosyncratic and expensive practice 
outside the public system. 
Increased referrals will result in 
greater demand in relation to num-
ber of diagnostic assessments, consul-
tation time and administrative tasks. 
With these new referrals will also 
come new responsibilities. There will 
be more onus on diagnosticians to 
test for other disorders prior to as-
sessing for ADHD, and changes to on-
set age will require greater attention 
to the temporal evolution of behav-
iors (Sibley et al., 2013). Thus, the clin-
ical implications of the new DSM-5 
conditions may not only be more pre-
sentations, but also more complex 
and time-consuming assessment. 
The changes in DSM-5 criteria 
will also have implications for physi-
cians’ interactions with the educa-
tion system. An emphasis on including 
teacher reports will present a number 
of practical difficulties. First, do teach-
ers have the capacity to produce re-
ports that are useful to clinicians? Sec-
ond, which teachers should report? In 
the primary school context (where 
a teacher spends hundreds of hours 
each year with the same student) this 
is less problematic. However, later on-
set age suggests that there will be in-
creased numbers assessed in the sec-
ondary school setting (where any 
given teacher may see over 150 stu-
dents each week for less than one 
hour a day). Third, how will clear and 
efficient lines of communication be 
established? 
There are also more general impli-
cations. Better communication will be 
required between the health profes-
sions to facilitate assessment and pro-
vide support across multiple settings. 
Better understandings of which med-
ical practitioners are assessing who 
and where will be needed to target 
training on best practice. And, if lev-
els of diagnosis increase, more public 
resources will be needed to expand 
multi-modal treatment, so that clini-
cians are not left prescribing medica-
tion as the only available support. 
Close analysis shows that the 
changes in the DSM-5 are more than 
just a tweak in terminology. The re-
sult is likely to be a growth in levels 
of diagnosis and increased demands 
on clinical, health and education 
professionals. 
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